Strategies to reduce oxidative stress in cardiovascular disease

Clinical Science

Volumn 106, Issue 3, 2004, Pages 219-234

  Hamilton, Carlene A ^a   Miller, William H ^a   Al Benna, Sammy ^a   Brosnan, M Julia ^a   Drummond, Russell D ^a   McBride, Martin W ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular disease; Gene therapy; Oxidative stress; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; AMLODIPINE; ANGIOTENSIN ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APOCYNIN; ARGININE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENYLIODONIUM SALT; DOXAZOSIN; ENZYME INHIBITOR; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; OXIPURINOL; RAMIPRIL; STREPTOZOCIN; THIOL DERIVATIVE; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE THERAPY; HEART FAILURE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OXIDATIVE STRESS; VITAMINS;

EID: 1642386719     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030379     Document Type: Review

References (204)

1. Landmesser, U. and Harrison, D. G. (2001) Oxidative stress and vascular damage in hypertension. Coron. Artery Dis. 12, 455-461
2. Cai, H. and Garrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ. Res. 87, 840-844
3. Griendling, K. K. and Ushio-Fukai, M. (1997) NADH/NADPH oxidase and vascular function. Trends Cardiovasc. Med. 7, 301-307
4. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B., Griendling, K. K. and Harrison, D. G. (1996) Angiotensin II-mediated hypertension in the rat increased vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916-1923
5. Meyer, J. W. and Schmitt, M. E. (2000) A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 472, 1-4
6. Berry, C., Hamilton, C. A., Brosnan, M. J., Magill, F. G., Berg, G. A., McMurray, J. J. V. and Dominiczak, A. F. (2000) Investigation into the sources of superoxide in human blood vessels. Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101, 2206-2212
7. Tiefenbacher, C. P. (2001) Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am. J. Physiol. Heart Circ. Physiol. 280, H2484-H2488
8. Wolin, M. S. (2000) Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20, 1430-1442
9. McBride, M. W., Farr, J. F., Graham, D. et al. (2003) Microarray analysis of rat chromosome 2 congenic strains. Hypertension 41, 847-853
10. phox gene on vascular superoxide production in atherosclerosis. Circulation 102, 1744-1747
11. McIntyre, M., Hamilton, C. A., Rees, D. D., Reid, J. L. and Dominiczak, A. F. (1997) Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension 30, 1517-1524
12. Kerr, S., Brosnan, M. J., McIntyre, M., Reid, J. L., Dominiczak, A. F. and Hamilton, C. A. (1999) Superoxide anion production is increased in a model of genetic hypertension: the role of the endothelium. Hypertension 33, 1353-1358
13. Bouloumie, A., Bauersachs, J., Linz, W., Scholkens, B. A., Wiemer, G., Fleming, I. and Busse, R. (1997) Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30, 934-941
14. Somers, M. J., Mavromatis, K., Galis, Z. S. and Harrison, D. G. (2000) Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101, 1722-1728
15. Nakazano, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T. and Inoue, M. (1991) Does superoxide underlie the pathogenesis of hypertension? Proc. Nat. Acad. Sci. U.S.A. 88, 10045-10048
16. 2α. Hypertension 33, 424-428
17. Vaziri, N. D., Wang, X. Q., Oveisi, F. and Rad, B. (2000) Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36, 142-146
18. Hamilton, C. A., Brosnan, M. J., McIntyre, M., Graham, D. and Dominiczak, A. F. (2001) Superoxide excess in hypertension and aging. A common cause of endothelial dysfunction. Hypertension 37, 529-534
19. Zalba, G., Jose, G. S., Moreno, M. U., Fortuno, M. A., Fortuno, A., Beaumont, F. J. and Diez, J. (2001) Oxidative stress in arterial hypertension. Role of NAD(P)H oxidase. Hypertension 38, 1395-1399
20. Aitman, T. J., Glazier, A. M., Wallace, C. A. et al. (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21, 76-83
21. Langenstroer, P. and Pieper, G. M. (1992) Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. 263, H257-H265
22. Kakkar, R., Manta, S. V., Kalra, J. and Prasad, K. (1996) Time course study of oxidative stress in aorta and heart of diabetic rat. Clin. Sci. 91, 441-448
23. Hink, U., Li, H., Mollnau, H. et al. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-E22
24. Kim, Y. K., Lee, M., Seok, M. S. et al. (2002) Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51, 522-527
25. Kamata, K. and Kobayashi, T. (1996) Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacol. 119, 583-589
26. Nishikawa, T., Edelstein, D., Du, X. L. et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (London) 404, 787-790
27. Hattori, Y., Kawasaki, H., Abe, K. and Kanno, M. (1991) Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261, H1086-H1094
28. Kashiwagi, A., Shinozaki, K., Nishio, Y. et al. (1999) Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am. J. Physiol. 277, 976-983
29. O'Hara, Y., Peterson, T. E. and Harrison, D. G. (1993) Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91, 2546-2551
30. Mugge, A., Brandes, R., Boger, R. H. et al. (1994) Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 24, 994
31. Mugge, A., Elwell, J. H., Peterson, T., Hofmeier, T. G., Heistad, D. D. and Harrison, D. G. (1991) Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69, 1293-1300
32. White, C. R., Brock, T. A., Chang L.-Y. et al. (1994) Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91, 1044-1048
33. Boger, R. H., Bode-Boger, S. M., Mugge, A., Kienke, S., Brandes, R., Dwenger, A. and Frolich, J. C. (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117, 273-284
34. Miller, Jr, F. J., Gutterman, D. D., Rios, C. D., Heistad, D. D. and Davidsonm, B. L. (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82, 1298-1305
35. Stepp, D. W., Ou, J., Acherman, A. W., Welak, S., Klick, D. and Pritchard, K. A. (2002) Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am. J. Physiol. Heart Circ. Physiol. 283, H750-H759
36. Warnholtz, A., Nickenig, G., Schulz, E. et al. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis. Evidence for involvement of the renin-angiotensin system. Circulation 99, 2027-2033
37. Hathaway, C. A., Heistad, D. D., Piegors, D. J. and Miller, F. J. (2002) Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ. Res. 90, 277-283
38. Cargnoni, A., Ceconi, C., Bernocchi, P., Boraso, A., Parrinello, G., Curello, S. and Ferrari, R. (2000) Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. Cardiovasc. Res. 47, 556-566
39. Ide, T., Tsutsui, H., Kinugawa, S. et al. (2000) Direct evidence for increased for hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157
40. Lang, D., Mosfer, S. I., Shakesby, A., Donaldson, F. and Lewis, M. J. (2000) Coronary microvascular endothelial cell redox state in left ventricular hypertrophy. The role of angiotensin II. Circ. Res. 86, 463-469
41. Li, J., Gall, N. P., Grieve, D. J., Chen, M. and Shah, A. M. (2002) Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40, 477-484
42. phox- containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293-296
43. MacCarthy, P. A., Grieve, D. J., Li, J., Dunster, C., Kelly, F. J. and Shah, A. M. (2001) Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy. Role of reactive oxygen species and NADPH oxidase. Circulation 104, 2967-2974
44. MacCarthy, P. A. and Shah, A. M. (2000) Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101, 1854-1860
45. Wiemer, G., Itter, G., Malinski, T. and Linz, W. (2001) Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. Hypertension 38, 1367-1371
46. Bauersachs, J., Bouloumie, A., Fraccarollo, D., Hu, K., Busse, R. and Ertl, G. (1999) Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Role of enhanced vascular superoxide production. Circulation 100, 292-298
47. Fuchs, L. C. (1996) Superoxide anions contribute to impaired endothelium-dependent relaxation in coronary arteries of young cardiomyopathic hamsters. Endothelium 4, 141-149
48. Koska, J., Syrova, D., Blazicek, P., Marko, M., Grna, J. D., Kvetnansky, R. and Vigas, M. (1999) Malondialdehyde, lipofuscin and activity of anti-oxidant enzymes during physical exercise in patients with essential hypertension. J. Hypertens. 17, 529-535
49. Orie, N. N., Zidek, W. and Tepel, M. (1999) Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am. J. Hypertens. 12, 1169-1174
50. Yasunari, K., Maeda, K., Nakamura, M. and Yoshikawa, J. (2002) Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39, 777-780
51. Redon, J., Oliva, M. R., Tormos, C., Giner, V., Chaves, J., Iradi, A. and Saez, G. T. (2003) Anti-oxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096-1101
52. Solzbach, U., Hornig, B., Jeserich, M. and Just, H. (1997) Vitamin C improves endothelial function dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96, 1513-1519
53. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A. and Salvetti, A. (1998) Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97, 2222-2229
54. Mehta, J. L., Lopez, L. M., Chen, L. and Cox, O. E. (1994) Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am. J. Cardiol. 74, 901-905
55. Lacy, F., O'Connor, D. T. and Schmid-Schonbein, G. W. (1998) Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J. Hypertens. 16, 291-303
56. Touyz, R. M., He, G., Wu, X., Park, J. B., Mabrouk, M. E. and Schiffrin, E. L. (2001) Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signalling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 38, 56-64
57. phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur. Heart J. 22, 96-101
58. phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145, 315-323
59. phox gene affects arterial compliance. Hypertension 42, 393
60. Ghiadoni, L., Virdis, A., Magagna, A., Taddei, S. and Salvetti, A. (2000) Effect of the angiotensin II type 1 receptor blocker Candesartan on endothelial function in patients with essential hypertension. Hypertension 35, 501-506
61. Abou-Seif, M. A. and Youssef, A. A. (2001) Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin. Chem. Lab. Med. 39, 618-623
62. Matkovics, B., Kotorman, M., Varga, I. S., Hai, D. Q., Roman, F. and Novak, Z. (1997-98) Pro-, anti-oxidant and filtration changes in the blood of type 1 diabetic patients. Acta Physiol. Hung. 85, 99-106
63. Matkovics, B., Kotorman, M., Varga, I. S., Hai, D. Q., Salgo, L. and Novak, Z. (1997-98) Pro-, anti-oxidant and rheologic studies in the blood of type 2 diabetic patients. Acta Physiol. Hung. 85, 107-112
64. Ruiz, C., Alegria, A., Barbera, R., Farre, R. and Lagarda, M. J. (1999) Lipid peroxidation and anti-oxidant enzyme activities in patients with type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 59, 99-105
65. Christ, M., Bauersachs, J., Liebetrau, C., Heck, M., Gunther, A. and Wehling, M. (2002) Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51, 2648-2652
66. Guzik, T. J., West, N. E. J., Black, E., McDonald, D., Ratnatunga, C., Pillai, R. and Channon, K. M. (2000) Vascular superoxide production by NAD(P)H oxidase. Association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, E85-E90
67. Marra, G., Cotroneo, P., Pitocco, D. et al. (2002) Early increase of oxidative stress and reduced anti-oxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25, 370-375
68. Ting, H. H., Timimi, F. K., Boles, K. S., Creager, S. J., Ganz, P. and Creager, M. A. (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97, 22-28
69. Witzum, J. L. (1994) The oxidation hypothesis of atherosclerosis. Lancet 17, 793-795
70. Nourooz-Zadeh, J., Smith, C. C. T. and Betteridge, D. J. (2001) Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Atherosclerosis 156, 435-441
71. Engler, M. M., Engler, M. B., Malloy, M. J. et al. (2003) Anti-oxidant vitamins C and E improve endothelial function in children with hyperlipidemia. Endothelial assessment of risk from lipids in youth (EARLY) trial. Circulation 108, 1059-1063
72. Bae, J. H., Bassenge, E., Kim, K. B. et al. (2001) Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155, 517-523
73. Kajanachumpol, S., Komindr, S. and Mahaisiriyodom, A. (1997) Plasma lipid peroxide and anti-oxidant levels in diabetic patients. J. Med. Assoc. Thai. 80, 372-377
74. Nacitarhan, S., Ozben, T. and Tuncer, N. (1995) Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radical Biol. Med. 19, 893-896
75. Anderson, R. A., Evans, M. L., Ellis, G. R. et al. (2001) The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 154, 475-483
76. Hiramatsu, K. and Arimori, S. (1988) Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 37, 832-837
77. Pronai, L., Hiramatsu, K., Saigusa, Y. and Nakazawa, H. (1991) Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis 90, 39-47
78. Doi, H., Kugiyama, K., Ohgushi, M. et al. (1999) Membrane active lipids in remnant lipoproteins cause impairment of endothelium dependent vasorelaxation. Arterioscler. Thromb. Vasc. Biol. 19, 1918-1924
79. Belch, J. J., Bridges, A. B., Scott, N. and Chopra, M. (1991) Oxygen free radicals and congestive heart failure. Br. Heart J. 65, 245-248
80. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. and Tedgui, A. (1998) Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97, 1536-1539
81. Treasure, C. B., Vita, J. A., Cox, D. A. et al. (1990) Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81, 772-779
82. McMurray, J., Chopra, M., Abdullah, I., Smith, W. E. and Dargie, H. J. (1993) Evidence of oxidative stress in chronic heart failure in humans. Eur. Heart J. 14, 1493-1498
83. Diaz-Velez, C. R., Garcia-Castineiras, S., Mendoza-Ramos, E. and Hernandez-Lopez, E. (1996) Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am. Heart J. 131, 146-152
84. Nishiyama, Y., Ikeda, H., Haramaki, N., Yoshida, N. and Imaizumi, T. (1998) Oxidative stress is related to exercise intolerance in patients with heart failure. Am. Heart J. 135, 115-120
85. Charney, R. H., Levy, D. K., Kalman, J., Buchholz, C., Ocampo, O. N., Eng, C. and Kukin, M. L. (1997) Free radical activity increases with NYHA class in congestive heart failure. J. Am. Coll. Cardiol. 29 (suppl.), 102A
86. Keith, M., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A. S. and Jeejeebhoy, K. N. (1998) Increased oxidative stress in patients with congestive heart failure. J. Am. Coll. Cardiol. 31, 1352-1356
87. Landmesser, U., Merten, R., Spiekermann, S., Buttner, K., Drexler, H. and Hornig, H. (2000) Vascular extracellular superoxide dismutase activity in patients with coronary artery disease. Relation to endothelium-dependent vasodilation. Circulation 101, 2264-2270
88. Berry, C. and Clark, A. L. (2000) Catabolism in chronic heart failure. Eur. Heart J. 21, 521-532
89. Cross, A. R. and Jones, O. T. G. (1991) Enzymatic mechanisms of superoxide production. Biochim. Biophys. Acta 1057, 281-298
90. phox-based NADH oxidase in vascular smooth muscle. Biochem. J. 329, 653-657
91. Ide, T., Tsutsui, H., Kinugawa, S. et al. (1999) Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85, 357-63
92. Ferrari, R., Agnoletti, L., Comini, L. et al. (1998) Oxidative stress during myocardial ischaemia and heart failure. Eur. Heart J. 19, B2-B11
93. Ellis, G. R., Anderson, R. A., Lang, D. et al. (2000) Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy. J. Am. Coll. Cardiol. 36, 1474-1482
94. Dieterich, S., Bieligk, U., Beulich, K., Hasenfuss, G. and Prestle, J. (2000) Gene expression of antioxidative enzymes in the human heart. Increased expression of catalase in the end-stage failing heart. Circulation 101, 33-39
95. Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J., Hasenfuss, G. and Shah, A. M. (2003) Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41, 2164-2171
96. Kanani, P. M., Sinkey, C. A., Browning, R. L., Allaman, M., Knapp, H. R. and Haynes, W. G. (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100, 1161-1168
97. Loscalzo, J. (1996) The oxidative stress of hyperhomocysteinemia. J. Clin. Invest. 98, 5-7
98. Kim, S. H., Kim, J. S., Shin, H. S. and Keen, C. L. (2003) Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 19, 240-243
99. Guthikonda, S., Sinkey, C., Barenz, T. and Haynes, W. G. (2003) Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107, 416-421
100. Yildiz, L., Kayaoglu, N. and Aksoy, H. (2002) The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin. Chem. Lab. Med. 40, 612-615
101. Polidori, M. C., Mecocci, P., Stahl, W. and Sies, H. (2003) Cigarette smoking cessation increases plasma levels of several anti-oxidant micronutrients and improves resistance towards oxidative challenge. Br. J. Nutr. 90, 147-150
102. Brown, K. M., Morrice, P. C. and Duthie, G. G. (1994) Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am. J. Clin. Nutr. 60, 383-387
103. Reilly, M., Delanty, N., Lawson, J. A. and FitzGerald, G. A. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 19-25
104. 2- isoprostanes in plasma of smokers. Cancer Epidemiol. Biomarkers Prev. 11, 7-13
105. Meyer, J. W., Holland, J. A., Ziegler, L. M., Chang, M. M., Beebe, G. and Schmitt, M. E. (1990) Identification of a function leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium 7, 11-22
106. Hamilton, C. A., Brosnan, M. J., Al-Benna, S., Berg, G. and Dominiczak, A. F. (2002) NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40, 755-762
107. Beswick, R. A., Dorrance, A. M., Leite, R. and Webb, C. (2001) NADH/ NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38, 1107-1111
108. - and systolic blood pressure in mice. Circ. Res. 89, 408-414
109. Cayatte, A. J., Rupin, A., Oliver-Krasinski, J. et al. (2001) S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler. Thromb. Vasc. Biol. 21, 1577-1584
110. Wagner, A. H., Köhler, T., Rückschloss, U., Just, I. and Hecker, M. (2000) Improvement of nitric oxide-dependent vasodilation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Vasc. Biol. 20, 61-69
111. Yasunari, K., Maeda, K., Minami, M. and Yoshikawa, J. (2001) HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscler. Thromb. Vasc. Biol. 21, 937-942
112. Delbose, S., Cristol, J. P., Descomps, B., Mimran, A. and Jover, B. (2002) Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 40, 142-147
113. Wassmann, S., Laufs, U., Baumer, A. T. et al. (2001) Inhibition of geranylgeranylation reduces antiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol. Pharmacol. 59, 646-654
114. Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A. and Harrison, D. G. (1997) Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95, 588-593
115. phox in aortas from angiotensin II-infused mice. Am. J. Physiol. Heart Circ. Physiol. 279, H2234-H2240
116. Wang, H. D., Xu, S., Johns, D. G., Du, Y., Quinn, M. R., Cayatte, A. J. and Cohen, R. A. (2001) Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88, 947-953
117. Touyz, R. M., He, G., Deng, L. Y. and Schiffrin, E. L. (1999) Role of ERK in Ang II-stimulated contraction of smooth muscle cells from human resistance vessels. Circulation 99, 392-399
118. Morawietz, H., Rueckschloss, U., Niemann, B. et al. (1999) Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 100, 899-902
119. Yusuf, S., Dagenais, G., Pogue, J. et al. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 154-160
120. Mancini, G. B., Henry, G. C., Macaya, C. et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease; the TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 94, 258-265
121. Rueckschloss, U., Quinn, M. T., Hotz, J. and Morawietz, H. (2002) Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells. Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 22, 1845-1851
122. Berry, C., Anderson, N., Kirk, A. J. B., Dominiczak, A. F. and McMurray, J. J. V. (2001) Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart 86, 217-220
123. Baykal, Y., Yilmaz Ilker, M., Celik, T., Gok, F., Refbar, H., Akay, C. and Kocar, I. H. (2003) Effects of antihypertensive agents, alpha blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J. Hypertens. 21, 1207-1211
124. Rimm, E. B. and Stampfer, M. J. (2000) Anti-oxidants for vascular disease. Med. Clin. North Am. 84, 239-249
125. Crawford, R. S., Kirk, E. A., Rosenfeld, M. E. et al. (1998) Dietary anti-oxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 1506-1513
126. Davidge, S. T., Ojimba, J. and McLaughlin, M. K. (1998) Vascular function in the vitamin E-deprived rat. An interaction between nitric oxide and superoxide anions. Hypertension 31, 830-835
127. Terasawa, Y., Ladha, Z., Leonard, S. W. et al. (2000) Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc. Natl. Acad. Sci. U.S.A. 97, 13830-13834
128. Jialal, I. and Devaraj, S. (2003) Anti-oxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107, 926-928
129. Gotoh, N., Noguchi, N., Tsuchiya, J., Morita, K., Sakai, H., Shimasaki, H. and Niki, E. (1996) Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds. Free Radical Res. 24, 123-134
130. Green, D., O'Driscoll, G., Rankin, J. M., Maiorana, A. J. and Taylor, R. R. (1998) Beneficial effect of vitamin E administration on nitric oxide function subjects with hypercholesterolaemia. Clin. Sci. 95, 361-363
131. Heitzer, T., Herttuala, S. Y., Wild, E., Luoma, J. and Drexler, H. (1999) Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J. Am. Coll. Cardiol. 33, 499-505
132. Hornig, B., Arakawa, N., Kohler, C. and Drexler, H. (1998) Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97, 363-368
133. Gokce, N., Keaney, Jr, J. F., Frei, B. et al. (1999) Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99, 3234-3240
134. Ülker, S., McKeown, P. P. and Bayraktutan, U. (2003) Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41, 534-539
135. Heller, R., Unbehaun, A., Schellenberg, B., Mayer, B., Werner-Felmayer, G. and Werner, E. R. (2001) L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276, 40-47
136. Huang, A., Vita, J. A., Venema, R. C. and Keaney, Jr, J. F. (2000) Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin. J. Biol. Chem. 275, 17399-17406
137. D'Uscio, L. V., Milstien, S., Richardson, D., Smith, L. and Katusic, Z. S. (2003) Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ. Res. 92, 88-95
138. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455
139. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of anti-oxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7-22
140. Collaborative Group of the Primary Prevention Project (PPP) (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 357, 89-95
141. Stephens, N. G., Parsons, A., Schofield, P. et al. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Anti-oxidant Study (CHAOS). Lancet 347, 781-786
142. Salonen, R. M., Nyyssonen, K., Kaikkomen, J. et al. (2003) Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107, 947-953
143. Landmesser, U. and Harrison, D. G. (2001) Oxidant stress as a marker for cardiovascular events. Ox marks the spot. Circulation 104, 2638-2640
144. John, J. H., Ziebland, S., Yudkin, P., Roe, L. S. and Neil, H. A. W. for the Oxford Fruit and Vegetable Study Group (2002) Effects of fruit and vegetable consumption on plasma anti-oxidant concentrations and blood pressure: a randomised controlled trial. Lancet 359, 1969-1974
145. Singh, N., Graves, J., Taylor, P. D., MacAllister, R. J. and Singer, D. R. J. (2002) Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovas. Res. 56, 118-125
146. Wollin, S. D. and Jones, P. J. H. (2001) Alcohol, red wine and cardiovascular disease. J. Nutr. 131, 1401-1404
147. Frankel, E. N., Kanner, J., German, J. B., Parks, E. and Kinsella, J. E. (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457
148. Stein, J. G., Keevil, J. G., Wiebe, D. A., Aeschlimann, S. and Folts, J. D. (1999) Purple grape juice improves endothelial function and reduces susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050-1055
149. Leikert, J. F., Räthel, T. R., Wohlfart, P., Cheynier, V., Vollmar, A. M. and Dirsch, V. M. (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106, 1614-1617
150. Kris-Etherton, P., Hecker, K. D. and Bonanome, A. (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113, 71S-88S
151. Clarkson, P., Adams, R. M., Powe, A. J. et al. (1996) Oral L-arginine improves endothelium-dependent dilation of hypercholesterolemic young adults. J. Clin. Invest. 97, 1989-1994
152. Tousoulis, D., Davies, G. J., Tentolouris, C., Crake, T. and Toutouzas, P. (1997) Coronary stenosis dilation induced by L-arginine. Lancet 349, 1812-1813
153. Loscalzo, J. (2000) What we know and don't know about L-arginine and NO. Circulation 101, 2126-2129
154. Lee, J., Ryu, H., Ferrante, R. J., Morris, S. M. and Ratan, R. R. (2003) Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. U.S.A. 100, 4843-4848
155. Midaoui, A. E. L. and Champlain, J. (2002) Prevention of hypertension, insulin resistance, and oxidative stress by α-lipoic acid. Hypertension 39, 303-307
156. Vasdev, S., Ford, C. A., Parai, S., Longerich, L. and Gadag, V. (2000) Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens. 18, 567-573
157. Tepel, M., Giet, M., Statz, M., Jankowski, J. and Zidek, W. (2003) The anti-oxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure, a randomized, controlled trial. Circulation 107, 992-995
158. Stampfer, M. J., Golditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E. and Hennekens, C. H. (1991) Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325, 756-762
159. Grundy, S. M., Balady, G. J., Criqui, M. H. et al. (1995) Guide to primary prevention of cardiovascular diseases: a statement for healthcare professionals from the Task Force on Risk Reduction. Circulation 92, 2-4
160. Gilligan, D. M., Qyyumi, A. A. and Cannon, III, R. O. (1994) Acute vascular effects of estrogen in postmenopausal women. Circulation 90, 786-791
161. Pinto, S., Virdis, A., Ghiadoni, L. et al. (1997) Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29, 268-273
162. Huang, A., Sun, D., Koller, A. and Kaley, G. (2000) 17β-Estradiol restores endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats. Circulation 101, 94-100
163. Barbacanne, M. A., Rami, J., Michel, J. B. et al. (1999) Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc. Res. 41, 672-681
164. Wagner, A. H., Schroeter, M. R. and Hecker, M. (2001) 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 15, 2121-2130
165. Haynes, M. P., Sinha, K., Russell, K. S. et al. (2000) Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677-682
166. Mendelsohn, M. E. (2000) Nongenomic, estrogen receptor-mediated activation of endothelial nitric oxide synthase. How does it work? What does it mean? Circ. Res. 87, 677-682
167. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W. and Liao, J. K. (2002) Interaction of estrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (London) 407, 538-541
168. Akishita, M., Ouchi, Y., Miyoshi, H. et al. (1996) Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis 125, 27-38
169. Bilsel, A. S., Mmoini, H., Tetik, E., Aksungar, F., Kaynak, B. and Özer, A. (2000) 17β-Estradiol modulates endothelin-1 expression and release in human endothelial cells. Cardiovas. Res. 46, 579-584
170. Hulley, S., Grady, D., Bushm, T. et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmeopausal women. JAMA, J. Am. Med. Assoc. 280, 605-613
171. Herrington, D. M., Reboussin, D. M., Brosnihan, K. B. et al. (2000) Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N. Engl. J. Med. 343, 522-529
172. Writing Group for the Women's Health Initiative Investigators (WHI) (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA, J. Am. Med. Assoc. 288, 321-333
173. Fontana, L., McNeill, K. L., Ritter, J. M. and Chowienczyk, P. J. (1999) Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br. J. Pharmacol. 126, 730-734
174. Cardillo, C., Kilcoyne, C. M., Cannon, R. O., Quyyumi, A. A. and Panza J. A. (1997) Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30, 57-63
175. Butler, R., Morris, A. D., Belch, J. J. F., Hill, A. and Struthers, A. D. (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35, 746-751
176. Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F. and Struthers, A. D. (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106, 221-226
177. Kullo, I. J., Mozes, G., Schwartz, R. S. et al. (1997) Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 96, 2254-2261
178. Kullo, I. J., Mozes, G., Schwartz, R. S., Gloviczki, P., Tsutsui, M., Katusic, Z. S. and O'Brien, T. (1997) Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 30, 314-320
179. Alexander, M. Y., Brosnan, M. J., Hamilton, C. A. et al. (1999) Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model. Cardiovasc. Res. 43, 798-807
180. Alexander, M. Y., Brosnan, M. J., Hamilton, C. A. et al. (2000) Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP. Cardiovasc. Res. 47, 609-617
181. Lund, D. D., Faraci, F. M., Miller, Jr, F. J. and Heistad, D. D. (2000) Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101, 1027-1033
182. Zanetti, M., Sato, J., Katusic, Z. S. and O'Brien, T. (2001) Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am. J. Physiol. Heart Circ. Physiol. 280, H2516-H2523
183. Nakane, H., Miller, Jr, F. J., Faraci, F. M., Toyoda, K. and Heistad, D. D. (2000) Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 35, 595-601
184. Ooboshi, H., Toyoda, K., Faraci, F. M., Lang, M. G. and Heistad, D. D. (1998) Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 18, 1752-1758
185. Mozes, G., Kullo, I. J., Mohacsi, T. G. et al. (1998) Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine. Atherosclerosis 141, 265-271
186. Wang, K., Kessler, P. D., Zhou, Z. et al. (2003) Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Mol. Ther. 7, 597-603
187. Shears, 2nd, L. L., Kibbe, M. R., Murdock, A. D. et al. (1998) Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg. 187, 295-306
188. Zanetti, M., D'uscio, L. V., Kovesdi, I., Katusic, Z. S. and O'Brien, T. (2003) In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits. Stroke 34, 1293-1298
189. Gunnett, C. A., Lund, D. D., Howard, 3rd, M. A., Chu, Y., Faraci, F. M. and Heistad, D. D. (2002) Gene transfer of inducible nitric oxide synthase impairs relaxation in human and rabbit cerebral arteries. Stroke 33, 2292-2296
190. West, N. E., Qian, H., Guzik, T. J., Black, E., Cai, S., George, S. E. and Channon, K. M. (2001) Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 104, 1526-1532
191. Channon, K. M., Qian, H., Neplioueva, V. et al. (1998) In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 98, 1905-1911
192. Zanetti, M., Sato, J., Jost, C. J., Gloviczki, P., Katusic, Z. S. and O'Brien, T. (2001) Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque. Hum. Gene Ther. 12, 1407-1416
193. Fennell, J. P., Brosnan, M. J., Frater, A. J. et al. (2002) Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther. 9, 110-117
194. Watanabe, Y., Chu, Y., Andresen, J. J., Nakane, H., Faraci, F. M. and Heistad, D. D. (2003) Gene transfer of extracellular Superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34, 434-440
195. Laukkanen, M. O., Kivela, A., Rissanen, T. et al. (2002) Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 106, 1999-2003
196. Chu, Y., Iida, S., Lund, D. D. et al. (2003) Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ. Res. 92, 461-468
197. Weiss, N., Zhang, Y. Y., Heydrick, S., Bierl, C. and Loscalzo, J. (2001) Overexpression of cellular glutathione peroxidase rescues homocyst(e) ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98, 12503-12508
198. Zanetti, M., Katusic, Z. S. and O'Brien, T. (2002) Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am. J. Physiol. Heart Circ. Physiol. 283, H2620-H2626
199. Erzurum, S. C., Lemarchand, P., Rosenfeld, M. A., Yoo, J. H. and Crystal, R. G. (1993) Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res. 21, 1607-1612
200. Lin, K. F., Chao, L. and Chao, J. (1997) Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 30, 307-313
201. Nicklin, S. A., Reynolds, P. N., Brosnan, M. J., White, S. J., Curiel, D. T., Dominiczak, A. F. and Baker, A. H. (2001) Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension 38, 65-70
202. Reynolds, P. N., Nicklin, S. A., Kaliberova, L. et al. (2001) Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat. Biotechnol. 19, 838-842
203. Baker, A. H. (2002) Development and use of gene transfer for treatment of cardiovascular disease. J. Card. Surg. 17, 543-548
204. Work, L. M., Nicklin, S. A. and Baker, A. H. (2003) Targeting gene therapy vectors to the vascular endothelium. Curr. Atheroscler. Rep. 5, 163-170